Clinical Trials
45 trialsA Study of Herbal Supplements in Cancer Survivors With Constipation
Memorial Sloan Kettering Cancer Center
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
SWOG Cancer Research Network
Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study
International University of Health and Welfare
Prevention of Constipation in Cancer Patients
Marmara University
Preop Laxatives in Robotic Urologic Surgery
University of Iowa
FMT-NENs
Second Affiliated Hospital, School of Medicine, Zhejiang University
GYVE
Laval University
PTNS and PFR in the Treatment of Childhood Constipation
Shengjing Hospital
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
SWOG Cancer Research Network
Effect of Laser Acupuncture on Constipation in Patients With Advanced Cancer
Chang Gung Memorial Hospital
Comparison of Gastrointestinal Motility in Healthy Children and Children With Constipation
University of Aarhus
Naloxegol in Cancer Opioid-Induced Constipation
University of California, San Diego
Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients
British Columbia Cancer Agency
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
Hospice of Henderson County, Inc.
Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for Chronic Pain
National Cancer Institute (NCI)
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
The Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain
Mundipharma Research GmbH & Co KG
Clinical Trial on Palliative Cancer Patients With Constipation
Hong Kong Baptist University
CLARO
Dartmouth-Hitchcock Medical Center
Changes in Patient Reported Constipation Among Advanced Cancer Patients After Receiving an Educational Intervention
M.D. Anderson Cancer Center
FIESTA
Sheffield Children's NHS Foundation Trust
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery
University of Illinois College of Medicine at Peoria
Managing Medication-induced Constipation in Cancer: A Clinical Trial
H. Lee Moffitt Cancer Center and Research Institute
Probiotic Therapy in Preventing Gastrointestinal Complications in Patients Undergoing Chemotherapy and Pelvic Radiation Therapy
Alliance for Clinical Trials in Oncology
Methylnaltrexone for Opioid-induced Constipation in Cancer Patients
University of Vermont
Nicotine in Treating "Hunger Pain" in Patients With Malignant Bowel Obstruction Caused By Cancer
Mayo Clinic
OXN3505
Mundipharma SAS
Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Clinical Evaluation Of Alvimopan (SB767905) On Constipation And Related Symptoms Associated With Opioid
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Random Comparison of LigaSure and Disposable Staples for Laparoscopic Surgery
University Hospitals Cleveland Medical Center
Naloxone SR Capsules in Patients With Opioid Induced Constipation
S.L.A. Pharma AG
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery
Northwestern University
Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction
Northwestern University
Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction
Northwestern University
Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.
Novartis
Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain
Novartis
Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.
Novartis
Prevention of Constipation: Systematic Nursing Interventions to Reduce Postoperative Constipation After Thoracic Surgery
Rigshospitalet, Denmark